September 4th, 2013
The standard pharmacological heart-failure treatment may not have changed much in the U.S. recently, but this fellow discovers different approaches in Europe and some potential new drugs on the horizon.
August 5th, 2013
Thirteen years after first being presented, the results of the PRAISE-2 trial finally have been published in JACC: Heart Failure. The trial itself is now largely irrelevant to current clinical practice, as the hypothesis it tested has long been abandoned, but the long delay in publication may serve to bring even more awareness to the issue […]